Venus MedTech, Inc.

Industry

  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive

Other Names/Subsidiaries

  • Cardiovalve Ltd.
  • Colibri/Venus Joint Venture Entity
  • InterValve
  • Transcatheter Technologies
  • Keystone Heart Ltd
  • 510 Kardiac Devices
  • Jilin Venus Haoyue Medtech Limited
See more in Biomedtracker

Latest on Venus MedTech, Inc.

In Vivo

The China Honeymoon Is Over: Global Medtech Must Think Decisively

 
• By Ashley Yeo

Market entry in China and the conditions for competing locally are becoming incrementally harder for foreign medtech innovators seeking to serve fast-growing patient demand in a population of 1.439 bi

Medtech Insight

Venus Continues To Drive TAVR In China By Licensing In Australian Start-Up Tech

 
• By Barnaby Pickering

Venus MedTech , the leading maker of transcatheter aortic heart valve replacement (TAVR) devices in China, has licensed Australia-based Endoluminal Sciences’ active anti-paravalvular leak (PVL) techno

Medtech Insight

Market Brief: Innovation Will Drive 13% Growth In Global Transcatheter Mitral Valve Repair Market by 2023, Outpacing Growth Of TAVR

 
• By Marion Webb

The global market for transcatheter heart valve management products, which includes TAVR systems and transcatheter mitral valve repair (TMVRep) products, is expected to grow at a compound annual growt

Medtech Insight

Market Intel: Martin Leon's TAVR Technology Tour Of The Future

 
• By Marion Webb

The first transcatheter aortic valve replacement (TAVR) was performed 16 years ago and it is now a well-entrenched part of cardiac care worldwide. Interventional cardiologist Martin Leon, one of the p